Ibogaine Research

Ibogaine Research

Ibogaine has been around as long as the Iboga plant has existed but science is just catching up with nature.
If you just heard about ibogaine it may seem like something out of a science fiction novel (and in fact may have inspired some of them). Yet, unbeknownst to many there is a huge library of research and reports about this medicine. It was discovered in 1864, used in the early 1900’s as Lambarene, and then the anti-addictive properties stumbled upon in the 1960’s. However, it hasn’t been until the last 30 years that scientists and doctors have really started exploring its potential. Ibogaine has been a schedule 1 drug for almost 60 years now. However, that has not stopped scientists from looking into its healing properties. If you do a search for Ibogaine on Pubmed, which contains the majority of the world’s scientific research, you will find over 400 results! In fact, here is a link: http://www.ncbi.nlm.nih.gov/pubmed/?term=ibogaine. The general consensus from the research is that, although Ibogaine has some complications, it is a powerful tool for aiding an individual in overcoming addiction and resetting their neural pathways.

Ibogaine Success Rates,
Efficacy Studies,
and Crossroads Research

You will find that many clinics and uninformed individuals will tell you that Ibogaine has a 70% or even 90% success rate, this is a sales tactic since most places only offer a 7-day treatment with Ibogaine. The actual success rate for a 7-day Ibogaine treatment seems to be around 30%, and every honest provider out there will tell you that there is much more work that must be done to ensure a 70% or higher successful addiction recovery for most individuals. We will happily explain more below as this has become a major focus at Crossroads. We had to ask ourselves, how can we help our guests be more successful? A study conducted in Holland some years ago showed that 25% of addicts completely quit hard drugs after a single treatment. Another 15% lost interest in the drugs after trying them again and then kept clean for at least six months. This represents a 40% success rate for 6 months, which isn’t bad, but could be much better. Out of the remaining 60% though, 25% found that it kept them clean at least for a month and the remaining 35% felt that an additional month of ibogaine treatments would have completely overcome their addiction. The overall success rate would have then gone up to an impressive 75% with just 4 more weeks of care. Subsequent studies all tend to agree on efficacy rate of up to 65% and higher for complete interruption withdrawal symptoms and addiction for individuals that commit to longer than just a 7-day Ibogaine treatment. We have recently completed an unprecedented Ibogaine research study that spans 5 years and over 100 former guests of our 7-day program. Here are some of our results:

  • 80% stated it was the best addiction treatment they had ever experienced and would do it again if needed
  • Around 30% stayed addiction free long-term with only a 7-day stay.
  • This is significantly better than the 5-10% success rate that conventional treatment options offer but we felt we could do better

For this reason, we have upgraded our treatment options and now we have found a way to almost ensure that 75% Ibogaine success rate and even higher. By allowing our guests to enter into a much longer and more expansive program we have seen tremendous initial results. We have seen a massive surge in Ibogaine treatment with success rates of up to 75% with only 4 more weeks of care. For individuals who wish to undergo our full program of 13 total weeks with us, we are seeing almost complete success, becoming a totally new individual, and erasing any ties to their past addiction. Crossroads Extended Ibogaine Treatment program is the first of it’s kind and will revolutionize both Ibogaine therapy and addiction treatment.

Further Research and Patents

 In 1985, Howard Lotsof was awarded a U.S. patent for ibogaine in opiate withdrawal. Other patents soon followed for cocaine, alcohol, nicotine, and polysubstance dependence. Those patents have expired by the 90’s making the profitability with pharmaceutical companies non-existant but it then became increasingly available in alternative settings in the U.S. and Europe. In 1994 and 1995, treatments using a conventional medical model setting were carried out in Panama, and in St. Kitts from 1996 until the early 2000’s. Then informal scenes were established around United States, Britain, Czech Republic, and Netherlands. From 1997, the first Ibogaine Mailing List began alongside increased use of internet in the ibogaine medical subculture. Clinical trials on ibogaine were brief in the early 1990’s and since then it has been left to personal reports and media to catalog what is happening around the world with the medicine. Many ibogaine addiction treatment centers have shot up in the last three decades. Between 2000 and 2005, ibogaine addiction treatment quadrupled globally even as its popularity is purely based on word of mouth. This is a show of high efficacy of ibogaine in addiction treatment. Going forward as we embark on a new understanding of the medicine and clinics, such as Crossroads performing real research and analysis of pre and post treatment, we know that everyone will soon know the great potential of this medicine to change addiction treatment and the world.